Skip to main content
Clinical Trials/KCT0001523
KCT0001523
Completed
未知

Autologous Adipose Tissue Derived Mesenchymal Stem Cells for Rotator Cuff Disease

Seoul Metropolitan Government Seoul National University Boramae Medical Center0 sites18 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the musculo-skeletal system and connective tissue
Sponsor
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Enrollment
18
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Seoul Metropolitan Government Seoul National University Boramae Medical Center

Eligibility Criteria

Inclusion Criteria

  • 1\. Age\>19 ,males and females
  • 2\. Unilateral shoulder pain
  • 3\. Symptomatic more than three months, Do not respond to conservative treatments
  • 4\. Partial\-thickness rotator cuff tears (evidenced by MR or ultrasonography)

Exclusion Criteria

  • 1\. Previous subacromial injection in past 3 months
  • 2\. History of shoulder dislocation, subluxation, fracture, breast cancer, cervical/shoulder/upper back surgery in past 6 months
  • 3\. Full\-thickness rotator cuff tears, adheisive capsulitis, acromioclavicular arthropathy
  • 4\. Radiological findings: malignancy, osteoarthritis of the glenohumeral joint, skeletal abnormalities decreasing the subacromial space
  • 5\. Symptomatic cervical spine disorders
  • 6\. Concurrent bilateral shoulder pain
  • 7\. Known or suspected polyarthritis, infectious arthritis, rheumatoid arthritis or diagnosed fibromyalgia
  • 8\. Neurological deficit
  • 9\. Pregnant, breastfeeding mothers
  • 10\. Patients of the must be practicing adequate contraception for the duration participation in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Autologous grafting of sonicated filtered lipoaspirate in single surgical sitting without using any enzyme or chemical in treatment of Osteoarthritis.
CTRI/2018/02/011844Sahaj Regenerative Cell Therapeutics LLP40
Completed
Not Applicable
se of stem cells in treatment of lung injuryAirway damage in chemical injuries.Chronic respiratory conditions due to chemicals, gases, fumes and vapours
IRCT2015110524890N1Veterans Foundation10
Active, not recruiting
Phase 1
Adipose Cell Derived Regenerative Endothelial and Angiogenic MedicinePatients with rest pain or ischemic ulcers/gangrene of the lower limb and without option for revascularization or poor option. Or patients with with rest pain or ischemic ulcers and persistent CLI after revascularization, or with severe cardiac, respiratory or renal disease who are at increased risk of complication from surgery or anesthesia, or with moderately severe or severe heart failure, severe or very severe Chronic Obstructive Pulmonary disease or severe renal disease.Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2018-000967-10-FRniversity Hospital Toulouse43
Recruiting
Phase 1/2
Adipose-derived mesenchymal stem cells as local treatment of ulcerative colitis
2024-518643-38-00Region Midtjylland16
Active, not recruiting
Not Applicable
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 18.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-001560-19-DKDepartment of Cardiology, Rigshospitalet